| Description |
Respiratory diseases are becoming more common, especially in children, and the demand for continued advancements in drug discovery has grown significantly in recent years. It is estimated that the commercial drug development market will grow to $23 billion by 2014, with 300 million people in the world suffering from Asthma, and COPD on the rise.
IQPC’s Asthma & COPD conference brings together leading pharmaceutical, biotech, R&D and medical device companies to discuss recent innovations in respiratory pipeline drug developments and delivery techniques.
|
|
